Complications of intrathecal therapy

Pain Medicine

Volumn 9, Issue SUPPL. 1, 2008, Pages

  Staats, Peter S ^a,b  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b Premier Pain Centers   (United States)

Author keywords

Complications; Intrathecal; Intrathecal delivery; Pumps

Indexed keywords

ANALGESIC AGENT; ANTIBIOTIC AGENT; BACLOFEN; CLONIDINE; FENTANYL; HYDROMORPHONE; LOCAL ANESTHETIC AGENT; METHADONE; MORPHINE; NARCOTIC ANALGESIC AGENT; OMEGA CONOTOXIN MVIIA; PLACEBO; SPASMOLYTIC AGENT;

ABNORMAL VISION; ADJUVANT THERAPY; ANALGESIA; ARTICLE; CANCER PAIN; CATHETER COMPLICATION; CATHETER REMOVAL; CENTRAL NERVOUS SYSTEM DISEASE; CEREBROSPINAL FLUID; CLINICAL TRIAL; CONFUSION; CONSTIPATION; DIZZINESS; DRUG DOSE REDUCTION; DRUG OVERDOSE; DRUG WITHDRAWAL; FLUOROSCOPY; GRANULOMA; HUMAN; INFECTION PREVENTION; INFUSION PUMP; INTRACTABLE PAIN; LIBIDO DISORDER; MONOTHERAPY; NAUSEA; NEUROLOGIC DISEASE; NEUROTOXICITY; NOCICEPTION; PAIN; POTENCY DISORDER; RESPIRATION DEPRESSION; RISK REDUCTION; SEDATION; SIDE EFFECT; SOMNOLENCE; SPASTICITY; TESTOSTERONE SYNTHESIS; URINE RETENTION;

EID: 44349143323     PISSN: 15262375     EISSN: 15264637     Source Type: Journal    
DOI: 10.1111/j.1526-4637.2008.00445.x     Document Type: Article

References (21)

1. Wang JK, Nauss LA, Thomas JE. Pain relief by intrathecally applied morphine in man. Anesthesiology 1979;50(2):149-51.
2. Smith T, Staats PS, Deer T, et al. Randomized clinical trial of an implanted drug delivery system compared to comprehensive medical management for refractory cancer pain: Impact on pain drug related toxicity and survival. J Clin Oncol 2002;20(19):4040-9.
3. Krames ES, Olson K. Clinical realities and economic considerations: Patient selection in intrathecal therapy. J Pain Symptom Manage 1997;14(suppl):S3-13.
4. Staats PS, Yearwood T, Charapata SG, et al. Intrathecal ziconotide in the treatment of refractory pain in patients with cancer or AIDS: A randomized controlled trial. JAMA 2004;291:63-70.
5. Wallace MS, Staats PS, Kosek PS, et al. Phase II open label multicenter study of combined intrathecal morphine and ziconotide in patients receiving intrathecal morphine for severe chronic pain. Pain Med 2007;9(3):271-81.
6. Wallace MS, Charapata S, Fisher R, et al. The ziconotide nonmalignant pain study group. Intrathecal ziconotide in the treatment of chronic nonmalignant pain: A randomized double blind placebo controlled trial. Neuromodulation 2006;9:75-86.
7. Hassenbusch SJ, Portenoy RK, Cousins M, et al. Polyanalgesic consensus conference 2003: An update o on the management of pain by intraspinal drug delivery-Report of an expert panel. J Pain Symptom Manage 2004;27(6):540-63.
8. Deer T, Krames ES, Hassenbusch SJ, et al. Polyanalgesic consensus conferencae 2007: Recommendations for the management of pain by intrathecal (intraspinal) drug delivery: Report of an interdisciplinary expert panel. Neuromodulation 2007;10(4):300-28.
9. Oakley J, Staats PS. The use of implanted drug delivery systems. In: Raj PP, ed. Practical Management of Pain, 3rd edition. St Louis, MO: Mosby; 2000:768-78.
10. Roberts LJ, Finch PM, Pullan PT, Bhagat CI, Price LM. Sex hormone suppression by intrathecal opioides: A prospective study. Clin J Pain 2002;18(3):144-8.
11. Finch PM. Hypogonadism in patients treated with intrathecal morphine. Clin J Pain 2000;16(3):251-4.
12. North RB, Cutchis PN, Epstein JA, Long DM. Spinal cord compression complicating subarachnoid infusion of morphine case report and laboratory experience. Neurosurgery 1991;29(5):778-84.
13. Yaksh TL, Horais KA, Tozier NA, et al. Chronically infused intrathecal morphine in dogs. Anesthesiology 2003;99(1):174-87.
14. Follet K. Intrathecal analgesia and catheter tip inflammatory masses. (Editorial). Anesthesiology 2003;99(1):5-6.
15. Cabbell KL, Taren JA, Sagher O. Spinal cord compression by catheter granulomas in high dose intrathecal morphine therapy: Case report. Neurosurgery 1998;42(5):1176-80.
16. Coffey RJ, Burchiel K. Inflammatory Mass lesions associated with intrathecal drug infusion catheters: Reports and observations on 41 patients. Neurosurgery 2002;50(1):78-86.
17. Allen JW, Horais KA, Tozier NA, et al. Time course and role of morphine dose and concentration in intrathecal granuloma formation in dogs: A combined magnetic resonance imaging and histopathology investigation. Anesthesiology 2006;105(3):581-9.
18. Allen JW, Horias KA, Tozier NA, Yaksh TL. Opiate pharmacology of intrathecal granulomas. Anesthesiology 2006;105(3):S590-7.
19. Murphy PM, Skouuvaklis DE, Amadeo RJ, Haberman C, Brazier DH, Cousins MJ. Intrathecal granuloma associated with isolated baclofen. Infusion. Anes Analg 2006;102(3):848-52.
20. McMillan MR, Doud T, Nugent W. Catheter associated masses in patients receiving intrathecal analgesic therapy. Anesth Analg 2003;96(1):186-90.
21. Prialt Package Insert